Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU0Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,871
Award facts
- Contract value 100% obligated
- $18,871.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,871.26 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 9, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 12, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle that runs through December 2026 and enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, leveraging its extensive distribution network and product portfolio to fulfill medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Trelegy Ellipta product being delivered is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease, consistent with the company's demonstrated capability to supply specialty and brand-name medications across multiple therapeutic domains. The award reflects Amerisourcebergen's ongoing role as a primary pharmaceutical distributor for federal military and veteran healthcare systems through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FQU0Y?
SPE2DR26FQU0Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FQU0Y worth?
The government has obligated $18,871 on SPE2DR26FQU0Y.
Is contract SPE2DR26FQU0Y an order under another contract?
Yes. SPE2DR26FQU0Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU0Y competed?
The extent of competition for SPE2DR26FQU0Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award